Cargando…
Ethical and public policy challenges for pharmacogenomics
It is timely to consider the ethical and social questions raised by progress in pharmacogenomics, based on the current importance of pharmacogenomics for avoidance of predictable side effects of drugs, and for correct choice of medications in certain cancers. It has been proposed that the entire pop...
Autores principales: | Gershon, Elliot S., Alliey-Rodriguez, Ney, Grennan, Kay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336925/ https://www.ncbi.nlm.nih.gov/pubmed/25733960 |
Ejemplares similares
-
A rare mutation of CACNA1C in a patient with Bipolar disorder, and decreased gene expression associated with a Bipolar-associated common SNP of CACNA1C in brain
por: Gershon, Elliot S., et al.
Publicado: (2013) -
Publication ethics
por: Sengupta, Sabyasachi, et al.
Publicado: (2017) -
Accuracy of CNV Detection from GWAS Data
por: Zhang, Dandan, et al.
Publicado: (2011) -
Genetic and genomic analyses as a basis for new diagnostic nosologies
por: Gershon, Elliot S., et al.
Publicado: (2015) -
Pharmacogenomic Testing In Pediatrics: Navigating The Ethical, Social, And Legal Challenges
por: Haga, Susanne B
Publicado: (2019)